Industry Research Reports
Home > Reports > Service & Software > Global Long Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Long Read Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-02-16
Pages: 134 Pages
Report ld: 5998711
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Long Read Sequencing Market Size(US$)
CAGR 2026-2032
8.7%
Market Size,2032
USD 4,490
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,722 million
Market Forecast in 2032(Value)
US$ 4,490 million
CAGR
8.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Long Read Sequencing market is projected to grow from US$ 2495 million in 2025 to US$ 4490 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Long Read Sequencing (LRS) represents a paradigm shift in genomics, moving from reconstructing the genome like a puzzle to reading it in near-contiguous pieces. Unlike Short Read Sequencing (SRS), which fragments DNA into pieces 150-300 base pairs long (requiring complex computational assembly), LRS reads single molecules in lengths of 10,000 to over 1,000,000 base pairs.
Market Drivers
1. Structural Variant (SV) Resolution (Clinical Driver)
Context: Short reads detect SNPs (single nucleotide variants) well. They miss 50-70% of structural variants (deletions, insertions, inversions, duplications >50bp).
Clinical Implication: SVs are implicated in autism, schizophrenia, epilepsy, cancer, and developmental disorders.
Driver: LRS detects SVs directly. No inference. The variant is seen in the read alignment.
Market Signal: Major medical centers (Mayo Clinic, Rady Children's, Broad) transitioning rare disease diagnostics to LRS.
2. Phasing & Haplotype Resolution (Mendelian Genetics)
The Problem: Humans are diploid. Short reads mix maternal and paternal alleles.
The Consequence: Cannot determine if two mutations are on the same chromosome (cis) or opposite (trans). Critical for recessive disease carrier status.
The Solution: Long reads span both variants. Native phasing.
Driver: Reproductive genetics. Carrier screening accuracy improvement.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Long Read Sequencing market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- BaseClear B.V.
- Future Genomics Technologies
- Garvan Institute of Medical Research
- Genome Transcriptome Facility of Bordeaux
- NextOmics
- Takara Bio
- Quantapore
- Roche
- MicrobesNG
- Institute of Integrative Biology of the Cell
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Consumables
- Instruments
- Services
Segment by Application
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other
Segment by Category
- Human Genetics and Biomedicine
- Microbiology and Infectious Disease
- Plant and Animal Sciences
- Functional Genomics and Transcriptomics
- Population and Evolutionary Genomics
Segment by Division
- PacBio (Single Molecule Real-Time; SMRT Sequencing)
- Oxford Nanopore Technologies (ONT)
- Emerging and Hybrid Technologies
CHAPTER OUTLINE
Chapter 1: Defines the Long Read Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Long Read Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Long Read Sequencing Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Services
1.3 Market Segmentation by Industry
1.3.1 Global Long Read Sequencing Market Size by Industry, 2021 vs 2025 vs 2032
1.3.2 Human Genetics and Biomedicine
1.3.3 Microbiology and Infectious Disease
1.3.4 Plant and Animal Sciences
1.3.5 Functional Genomics and Transcriptomics
1.3.6 Population and Evolutionary Genomics
1.4 Market Segmentation by Technology
1.4.1 Global Long Read Sequencing Market Size by Technology, 2021 vs 2025 vs 2032
1.4.2 PacBio (Single Molecule Real-Time; SMRT Sequencing)
1.4.3 Oxford Nanopore Technologies (ONT)
1.4.4 Emerging and Hybrid Technologies
1.5 Market Segmentation by Application
1.5.1 Global Long Read Sequencing Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Academic Research
1.5.3 Clinical Research
1.5.4 Hospitals & Clinics
1.5.5 Pharma & Biotech Entities
1.5.6 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Long Read Sequencing Revenue Estimates and Forecasts (2021-2032)
2.2 Global Long Read Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Long Read Sequencing Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Long Read Sequencing Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Consumables: Market Share by Key Players
3.3.2 Instruments: Market Share by Key Players
3.3.3 Services: Market Share by Key Players
3.4 Global Long Read Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Long Read Sequencing Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Long Read Sequencing Market by Industry
4.2.1 Global Revenue by Industry (2021-2032)
4.2.2 Global Revenue-Based Market Share by Industry (2021-2032)
4.3 Global Long Read Sequencing Market by Technology
4.3.1 Global Revenue by Technology (2021-2032)
4.3.2 Global Revenue-Based Market Share by Technology (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Long Read Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Long Read Sequencing Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Long Read Sequencing Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Long Read Sequencing Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Long Read Sequencing Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Long Read Sequencing Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Long Read Sequencing Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Long Read Sequencing Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Long Read Sequencing Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Long Read Sequencing Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Long Read Sequencing Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Oxford Nanopore Technologies
11.1.1 Oxford Nanopore Technologies Corporation Information
11.1.2 Oxford Nanopore Technologies Business Overview
11.1.3 Oxford Nanopore Technologies Long Read Sequencing Product Features and Attributes
11.1.4 Oxford Nanopore Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.1.5 Oxford Nanopore Technologies Long Read Sequencing Revenue by Product in 2025
11.1.6 Oxford Nanopore Technologies Long Read Sequencing Revenue by Application in 2025
11.1.7 Oxford Nanopore Technologies Long Read Sequencing Revenue by Geographic Area in 2025
11.1.8 Oxford Nanopore Technologies Long Read Sequencing SWOT Analysis
11.1.9 Oxford Nanopore Technologies Recent Developments
11.2 Pacific Biosciences of California
11.2.1 Pacific Biosciences of California Corporation Information
11.2.2 Pacific Biosciences of California Business Overview
11.2.3 Pacific Biosciences of California Long Read Sequencing Product Features and Attributes
11.2.4 Pacific Biosciences of California Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.2.5 Pacific Biosciences of California Long Read Sequencing Revenue by Product in 2025
11.2.6 Pacific Biosciences of California Long Read Sequencing Revenue by Application in 2025
11.2.7 Pacific Biosciences of California Long Read Sequencing Revenue by Geographic Area in 2025
11.2.8 Pacific Biosciences of California Long Read Sequencing SWOT Analysis
11.2.9 Pacific Biosciences of California Recent Developments
11.3 BaseClear B.V.
11.3.1 BaseClear B.V. Corporation Information
11.3.2 BaseClear B.V. Business Overview
11.3.3 BaseClear B.V. Long Read Sequencing Product Features and Attributes
11.3.4 BaseClear B.V. Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.3.5 BaseClear B.V. Long Read Sequencing Revenue by Product in 2025
11.3.6 BaseClear B.V. Long Read Sequencing Revenue by Application in 2025
11.3.7 BaseClear B.V. Long Read Sequencing Revenue by Geographic Area in 2025
11.3.8 BaseClear B.V. Long Read Sequencing SWOT Analysis
11.3.9 BaseClear B.V. Recent Developments
11.4 Future Genomics Technologies
11.4.1 Future Genomics Technologies Corporation Information
11.4.2 Future Genomics Technologies Business Overview
11.4.3 Future Genomics Technologies Long Read Sequencing Product Features and Attributes
11.4.4 Future Genomics Technologies Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.4.5 Future Genomics Technologies Long Read Sequencing Revenue by Product in 2025
11.4.6 Future Genomics Technologies Long Read Sequencing Revenue by Application in 2025
11.4.7 Future Genomics Technologies Long Read Sequencing Revenue by Geographic Area in 2025
11.4.8 Future Genomics Technologies Long Read Sequencing SWOT Analysis
11.4.9 Future Genomics Technologies Recent Developments
11.5 Garvan Institute of Medical Research
11.5.1 Garvan Institute of Medical Research Corporation Information
11.5.2 Garvan Institute of Medical Research Business Overview
11.5.3 Garvan Institute of Medical Research Long Read Sequencing Product Features and Attributes
11.5.4 Garvan Institute of Medical Research Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.5.5 Garvan Institute of Medical Research Long Read Sequencing Revenue by Product in 2025
11.5.6 Garvan Institute of Medical Research Long Read Sequencing Revenue by Application in 2025
11.5.7 Garvan Institute of Medical Research Long Read Sequencing Revenue by Geographic Area in 2025
11.5.8 Garvan Institute of Medical Research Long Read Sequencing SWOT Analysis
11.5.9 Garvan Institute of Medical Research Recent Developments
11.6 Genome Transcriptome Facility of Bordeaux
11.6.1 Genome Transcriptome Facility of Bordeaux Corporation Information
11.6.2 Genome Transcriptome Facility of Bordeaux Business Overview
11.6.3 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Product Features and Attributes
11.6.4 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.6.5 Genome Transcriptome Facility of Bordeaux Recent Developments
11.7 NextOmics
11.7.1 NextOmics Corporation Information
11.7.2 NextOmics Business Overview
11.7.3 NextOmics Long Read Sequencing Product Features and Attributes
11.7.4 NextOmics Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.7.5 NextOmics Recent Developments
11.8 Takara Bio
11.8.1 Takara Bio Corporation Information
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Long Read Sequencing Product Features and Attributes
11.8.4 Takara Bio Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.8.5 Takara Bio Recent Developments
11.9 Quantapore
11.9.1 Quantapore Corporation Information
11.9.2 Quantapore Business Overview
11.9.3 Quantapore Long Read Sequencing Product Features and Attributes
11.9.4 Quantapore Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.9.5 Quantapore Recent Developments
11.10 Roche
11.10.1 Roche Corporation Information
11.10.2 Roche Business Overview
11.10.3 Roche Long Read Sequencing Product Features and Attributes
11.10.4 Roche Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 MicrobesNG
11.11.1 MicrobesNG Corporation Information
11.11.2 MicrobesNG Business Overview
11.11.3 MicrobesNG Long Read Sequencing Product Features and Attributes
11.11.4 MicrobesNG Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.11.5 MicrobesNG Recent Developments
11.12 Institute of Integrative Biology of the Cell
11.12.1 Institute of Integrative Biology of the Cell Corporation Information
11.12.2 Institute of Integrative Biology of the Cell Business Overview
11.12.3 Institute of Integrative Biology of the Cell Long Read Sequencing Product Features and Attributes
11.12.4 Institute of Integrative Biology of the Cell Long Read Sequencing Revenue and Gross Margin (2021-2026)
11.12.5 Institute of Integrative Biology of the Cell Recent Developments
12 Long Read Sequencing Value Chain and Ecosystem Analysis
12.1 Long Read Sequencing Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Long Read Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Long Read Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Long Read Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Long Read Sequencing Market Size Growth Rate by Industry, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Long Read Sequencing Market Size Growth Rate by Technology, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Long Read Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Long Read Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Long Read Sequencing Revenue by Region (US$ Million), 2021-2026
Table 7. Global Long Read Sequencing Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Long Read Sequencing Revenue by Players (US$ Million), 2021-2026
Table 10. Global Long Read Sequencing Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Long Read Sequencing Revenue, 2025
Table 13. Global Long Read Sequencing Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Long Read Sequencing Companies Headquarters
Table 15. Global Long Read Sequencing Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Long Read Sequencing Revenue by Type (US$ Million), 2021-2026
Table 19. Global Long Read Sequencing Revenue by Type (US$ Million), 2027-2032
Table 20. Global Long Read Sequencing Revenue by Industry (US$ Million), 2021-2026
Table 21. Global Long Read Sequencing Revenue by Industry (US$ Million), 2027-2032
Table 22. Global Long Read Sequencing Revenue by Technology (US$ Million), 2021-2026
Table 23. Global Long Read Sequencing Revenue by Technology (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Long Read Sequencing Revenue by Application (US$ Million), 2021-2026
Table 26. Global Long Read Sequencing Revenue by Application (US$ Million), 2027-2032
Table 27. Long Read Sequencing High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Long Read Sequencing Growth Accelerators and Market Barriers
Table 31. North America Long Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Long Read Sequencing Growth Accelerators and Market Barriers
Table 33. Europe Long Read Sequencing Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Long Read Sequencing Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Long Read Sequencing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Long Read Sequencing Investment Opportunities and Key Challenges
Table 37. Central and South America Long Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Long Read Sequencing Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Long Read Sequencing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Oxford Nanopore Technologies Corporation Information
Table 41. Oxford Nanopore Technologies Description and Major Businesses
Table 42. Oxford Nanopore Technologies Product Features and Attributes
Table 43. Oxford Nanopore Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Oxford Nanopore Technologies Revenue Proportion by Product in 2025
Table 45. Oxford Nanopore Technologies Revenue Proportion by Application in 2025
Table 46. Oxford Nanopore Technologies Revenue Proportion by Geographic Area in 2025
Table 47. Oxford Nanopore Technologies Long Read Sequencing SWOT Analysis
Table 48. Oxford Nanopore Technologies Recent Developments
Table 49. Pacific Biosciences of California Corporation Information
Table 50. Pacific Biosciences of California Description and Major Businesses
Table 51. Pacific Biosciences of California Product Features and Attributes
Table 52. Pacific Biosciences of California Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Pacific Biosciences of California Revenue Proportion by Product in 2025
Table 54. Pacific Biosciences of California Revenue Proportion by Application in 2025
Table 55. Pacific Biosciences of California Revenue Proportion by Geographic Area in 2025
Table 56. Pacific Biosciences of California Long Read Sequencing SWOT Analysis
Table 57. Pacific Biosciences of California Recent Developments
Table 58. BaseClear B.V. Corporation Information
Table 59. BaseClear B.V. Description and Major Businesses
Table 60. BaseClear B.V. Product Features and Attributes
Table 61. BaseClear B.V. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. BaseClear B.V. Revenue Proportion by Product in 2025
Table 63. BaseClear B.V. Revenue Proportion by Application in 2025
Table 64. BaseClear B.V. Revenue Proportion by Geographic Area in 2025
Table 65. BaseClear B.V. Long Read Sequencing SWOT Analysis
Table 66. BaseClear B.V. Recent Developments
Table 67. Future Genomics Technologies Corporation Information
Table 68. Future Genomics Technologies Description and Major Businesses
Table 69. Future Genomics Technologies Product Features and Attributes
Table 70. Future Genomics Technologies Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Future Genomics Technologies Revenue Proportion by Product in 2025
Table 72. Future Genomics Technologies Revenue Proportion by Application in 2025
Table 73. Future Genomics Technologies Revenue Proportion by Geographic Area in 2025
Table 74. Future Genomics Technologies Long Read Sequencing SWOT Analysis
Table 75. Future Genomics Technologies Recent Developments
Table 76. Garvan Institute of Medical Research Corporation Information
Table 77. Garvan Institute of Medical Research Description and Major Businesses
Table 78. Garvan Institute of Medical Research Product Features and Attributes
Table 79. Garvan Institute of Medical Research Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Garvan Institute of Medical Research Revenue Proportion by Product in 2025
Table 81. Garvan Institute of Medical Research Revenue Proportion by Application in 2025
Table 82. Garvan Institute of Medical Research Revenue Proportion by Geographic Area in 2025
Table 83. Garvan Institute of Medical Research Long Read Sequencing SWOT Analysis
Table 84. Garvan Institute of Medical Research Recent Developments
Table 85. Genome Transcriptome Facility of Bordeaux Corporation Information
Table 86. Genome Transcriptome Facility of Bordeaux Description and Major Businesses
Table 87. Genome Transcriptome Facility of Bordeaux Product Features and Attributes
Table 88. Genome Transcriptome Facility of Bordeaux Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Genome Transcriptome Facility of Bordeaux Recent Developments
Table 90. NextOmics Corporation Information
Table 91. NextOmics Description and Major Businesses
Table 92. NextOmics Product Features and Attributes
Table 93. NextOmics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. NextOmics Recent Developments
Table 95. Takara Bio Corporation Information
Table 96. Takara Bio Description and Major Businesses
Table 97. Takara Bio Product Features and Attributes
Table 98. Takara Bio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. Takara Bio Recent Developments
Table 100. Quantapore Corporation Information
Table 101. Quantapore Description and Major Businesses
Table 102. Quantapore Product Features and Attributes
Table 103. Quantapore Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Quantapore Recent Developments
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Product Features and Attributes
Table 108. Roche Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Roche Recent Developments
Table 110. MicrobesNG Corporation Information
Table 111. MicrobesNG Description and Major Businesses
Table 112. MicrobesNG Product Features and Attributes
Table 113. MicrobesNG Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. MicrobesNG Recent Developments
Table 115. Institute of Integrative Biology of the Cell Corporation Information
Table 116. Institute of Integrative Biology of the Cell Description and Major Businesses
Table 117. Institute of Integrative Biology of the Cell Product Features and Attributes
Table 118. Institute of Integrative Biology of the Cell Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. Institute of Integrative Biology of the Cell Recent Developments
Table 120. Technologies, Platforms and Infrastructure
Table 121. Distributors List
Table 122. Market Trends and Market Evolution
Table 123. Market Drivers and Opportunities
Table 124. Market Challenges, Risks, and Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Read Sequencing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Consumables Product Picture
Figure 3. Instruments Product Picture
Figure 4. Services Product Picture
Figure 5. Global Long Read Sequencing Market Size Growth Rate by Industry, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Human Genetics and Biomedicine Product Picture
Figure 7. Microbiology and Infectious Disease Product Picture
Figure 8. Plant and Animal Sciences Product Picture
Figure 9. Functional Genomics and Transcriptomics Product Picture
Figure 10. Population and Evolutionary Genomics Product Picture
Figure 11. Global Long Read Sequencing Market Size Growth Rate by Technology, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. PacBio (Single Molecule Real-Time; SMRT Sequencing) Product Picture
Figure 13. Oxford Nanopore Technologies (ONT) Product Picture
Figure 14. Emerging and Hybrid Technologies Product Picture
Figure 15. Global Long Read Sequencing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Academic Research
Figure 17. Clinical Research
Figure 18. Hospitals & Clinics
Figure 19. Pharma & Biotech Entities
Figure 20. Other
Figure 21. Long Read Sequencing Report Years Considered
Figure 22. Global Long Read Sequencing Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 24. Global Long Read Sequencing Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global Long Read Sequencing Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global Long Read Sequencing Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Consumables Revenue-Based Market Share by Player in 2025
Figure 29. Instruments Revenue-Based Market Share by Player in 2025
Figure 30. Services Revenue-Based Market Share by Player in 2025
Figure 31. Global Long Read Sequencing Revenue-Based Market Share by Type (2021-2032)
Figure 32. Global Long Read Sequencing Revenue-Based Market Share by Industry (2021-2032)
Figure 33. Global Long Read Sequencing Revenue-Based Market Share by Technology (2021-2032)
Figure 34. Global Long Read Sequencing Revenue-Based Market Share by Application (2021-2032)
Figure 35. North America Long Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 36. North America Top 5 Players Long Read Sequencing Revenue (US$ Million) in 2025
Figure 37. North America Long Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 38. US Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 39. Canada Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 40. Mexico Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 41. Europe Long Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 42. Europe Top 5 Players Long Read Sequencing Revenue (US$ Million) in 2025
Figure 43. Europe Long Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 44. Germany Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 45. France Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 46. U.K. Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 47. Italy Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 48. Russia Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 49. Asia-Pacific Long Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 50. Asia-Pacific Top 8 Players Long Read Sequencing Revenue (US$ Million) in 2025
Figure 51. Asia-Pacific Long Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 52. Indonesia Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 53. Japan Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 54. South Korea Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 55. Australia Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 56. India Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 57. Indonesia Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 58. Vietnam Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 59. Malaysia Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 60. Philippines Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 61. Singapore Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 62. Central and South America Long Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 63. Central and South America Top 5 Players Long Read Sequencing Revenue (US$ Million) in 2025
Figure 64. Central and South America Long Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 65. Brazil Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 66. Argentina Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 67. Middle East and Africa Long Read Sequencing Revenue YoY (US$ Million), 2021-2032
Figure 68. Middle East and Africa Top 5 Players Long Read Sequencing Revenue (US$ Million) in 2025
Figure 69. Middle East and Africa Long Read Sequencing Revenue (US$ Million) by Application (2021-2032)
Figure 70. GCC Countries Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 71. Israel Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 72. Egypt Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 73. South Africa Long Read Sequencing Revenue (US$ Million), 2021-2032
Figure 74. Long Read Sequencing Value Chain Mapping
Figure 75. Channels of Distribution (Direct Vs Distribution)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Long Read Sequencing in 2032?
The global market size of Long Read Sequencing in 2032 was 4490 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Long Read Sequencing market size from 2026 to 2032?
Which companies rank high in the global Long Read Sequencing market?
What was the global market size of Long Read Sequencing in 2026?
Related Reports
Global Long Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long Read Sequencing market size was US$ 2495 million in 2025 and is forecast to reach a readjusted size of US$ 4490 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published Date: 2026-02-16
Pages: 92
USD 4250.00
(Single User License)
Global Long Read Sequencing Market Research Report 2026
The global Long Read Sequencing market was valued at US$ 2495 million in 2025 and is anticipated to reach US$ 4490 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-02-16
Pages: 117
USD 2900.00
(Single User License)
Long Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long Read Sequencing was estimated to be worth US$ 2495 million in 2025 and is projected to reach US$ 4490 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-02-16
Pages: 117
USD 3950.00
(Single User License)
Global Long Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long Read Sequencing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 92
USD 4250.00
(Single User License)
Long Read Sequencing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long Read Sequencing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 105
USD 3950.00
(Single User License)
Global Long Read Sequencing Market Research Report 2025
The global market for Long Read Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 88
USD 2900.00
(Single User License)
Global Long Read Sequencing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Long Read Sequencing Market
Published Date: 2024-04-06
Pages: 113
USD 4900.00
(Single User License)
Global Long Read Sequencing Market Research Report 2024
The global Long Read Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 81
USD 2900.00
(Single User License)
Global Long Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Long Read Sequencing market size was US$ 2495 million in 2025 and is forecast to reach a readjusted size of US$ 4490 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published: 2026-02-16
Pages: 92
USD 4250.00 (Single User License)Global Long Read Sequencing Market Research Report 2026
The global Long Read Sequencing market was valued at US$ 2495 million in 2025 and is anticipated to reach US$ 4490 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-02-16
Pages: 117
USD 2900.00 (Single User License)Long Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Long Read Sequencing was estimated to be worth US$ 2495 million in 2025 and is projected to reach US$ 4490 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-02-16
Pages: 117
USD 3950.00 (Single User License)Global Long Read Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Long Read Sequencing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 92
USD 4250.00 (Single User License)Long Read Sequencing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Long Read Sequencing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 105
USD 3950.00 (Single User License)Global Long Read Sequencing Market Research Report 2025
The global market for Long Read Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 88
USD 2900.00 (Single User License)Global Long Read Sequencing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Long Read Sequencing Market
Published: 2024-04-06
Pages: 113
USD 4900.00 (Single User License)Global Long Read Sequencing Market Research Report 2024
The global Long Read Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 81
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now